Why do some innovations fail? Even the best inventions can be hindered when it comes to adoption, integration and delivery. This can happen when risk has not been assessed and addressed before an innovation is rolled out in the real world.
There is no shortage of good ideas in healthcare. The difficult bit is turning them into something that genuinely works for patients, staff and the wider system.
In his latest article, ACE Healthcare Customer Engagement Lead Waleed Backler explores what de-risking innovation means for the healthcare sector and why identifying risks, testing assumptions and learning early really matters.
Read Waleed’s original article on LinkedIn – Post | LinkedIn
Trying something genuinely different will always bring some uncertainty.
At ACE, we test how healthcare innovation can support earlier diagnosis, timely intervention and more personalised care across the UK. We work in areas where we don’t always have all the answers, so identifying risks, testing assumptions and learning early really matters.
Innovation is not always invention.
Too often innovation is confused with invention.
Something can be new, exciting and technically impressive without necessarily solving the problem it was designed to address. Equally, innovation doesn’t always have to involve inventing something completely new.
It can mean applying existing technology differently, bridging a gap, improving a pathway or simply finding a better way of tackling an age-old problem.
So, we need to start with the challenge and who it affects, not the technology.
Why does the problem exist? What are we trying to change? And what would better actually look like?
Genuine innovation happens when those questions can be answered and the solution leads to something that can make a meaningful difference in the real world. But identifying the right problem and developing a promising solution is only part of the challenge. Getting it adopted, integrated and scaled across healthcare is another.
Testing in the real world
A solution must work for the people using it and should function within existing pathways, infrastructure and current ways of working. Something that works well in one setting may not necessarily work in another, and understanding those differences is an important part of the innovation process.
This is why testing matters, so we can focus on solving real-life operational challenges and challenges faced by clinicians and patients, rather than simply demonstrating that the technology works.
Moving quickly shouldn’t mean deploying faster. It should mean testing assumptions, learning what works and adapting while there is still time to do so.
We need to move from “this looks promising” to “we understand where and how this can work and how it will make a difference.”
Understanding risk early
Understanding the risks involved is an important part of that process, particularly for AI-enabled technologies.
Risk doesn’t suddenly appear at the point of deployment, and our understanding of it shouldn’t start or stop there either.
Crucially, this isn’t about creating another barrier to innovation. It’s about understanding the risks early enough to adjust and make better decisions. Sometimes discovering quickly that an approach isn’t going to work is a valuable outcome in itself.
That means starting with the problem, involving the right expertise early, testing assumptions in real-world settings and building evidence and learning into the process.
Because if we only assess risk when a solution is ready to deploy, we may already have left it too late.
https://ace.blog.gov.uk/2026/11/17/healthcare-innovation-making-it-work-in-the-real-world/
Healthcare innovation: making it work in the real world
Posted by:
sshah, Posted on:
-
Categories:
Artificial Intelligence, Data, Data science, Healthcare, Innovation